Nicolas Killen

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Borel & Barbey is a law firm based in Geneva, Switzerland since 1907. With over sixty legal specialists, the firm provides services in various areas such as banking and finance, private clients, corporate, litigation and arbitration, family, real estate, tax, and labor. The firm is known for its strong values, including a high-quality relationship with its clients.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

NS Partners SA, also known as Notz, Stucki Europe SA, is a fully licensed Swiss management company that provides a one-stop-shop solution to set up and manage custom investment vehicles. NS Partners is based in Geneva, CH, and has subsidiaries in Switzerland, Luxembourg, British Virgin Islands, Bermuda, and Panama. NS Partners offers Notz Stucki Funds and White-Label structures managed by their Luxembourg Fully Licensed Management Company. The private company guides its clients through the complexities of the financial world and finds the most appropriate solution to help structure, protect, and increase their assets. The company was founded in 1964 by Beat Notz and Christian Stucki, and today, it has eight offices worldwide and over 100 skilled employees. Cédric Dingens has been the CEO of the company since 2006.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.